UbcH5c-IN-1
UbcH5c-IN-1 (compound 6d) is a potent and selective small-molecule inhibitor of Ubiquitin-conjugating enzyme UbcH5c, with a Kd of 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85. A promising lead compound for the development of new antirheumatoid arthritis (RA) agent[1].
Product Specifications
CAS Number
2123480-72-6
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/UbcH5c-IN-1.html
Purity
99.84
Solubility
DMSO : 20 mg/mL (ultrasonic)
Smiles
BrC1=CC=CC=C1COC2=C(C)C([C@H](OC(C3=C)=O)[C@H]3CC4)=C4C(C)=C2
Molecular Formula
C22H21BrO3
Molecular Weight
413.30
References & Citations
[1]Chen H, et al. Discovery of Potent Small-Molecule Inhibitors of Ubiquitin-Conjugating Enzyme UbcH5c from α-Santonin Derivatives. J Med Chem. 2017 Aug 24;60 (16) :6828-6852.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC424184 20 µg
Apc11 (ANAPC11) (NM_001002247) Human Over-expression Lysate
Sign In for Pricing
View Details 
HA723359 100 µL
Claudin 18.2 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
